Literature DB >> 12901909

Synthesis and structure-activity relationships of 2-substituted-8-hydroxyadenine derivatives as orally available interferon inducers without emetic side effects.

Yoshiaki Isobe1, Masanori Tobe, Haruhisa Ogita, Ayumu Kurimoto, Tetsuhiro Ogino, Hajime Kawakami, Haruo Takaku, Hironao Sajiki, Kosaku Hirota, Hideya Hayashi.   

Abstract

Recently we reported the adenine derivatives (2-4) as new interferon (IFN) inducers. In the present study, we conducted a detailed structure and activity relationship study of 4 and its related derivatives on IFN inducing activity. From this study, we found that compound 4 exhibited the most potent IFN inducing activity in vitro with a minimum effective concentration of 0.01 microM, and 4 also showed strong IFN-inducing activity at doses of more than 0.3mg/kg by oral administration in mice. This potency was 10-fold stronger than that of Imiquimod. Moreover, 4 did not cause emesis in ferrets even at doses as high as 10mg/kg, whereas, 80% of animals were emetic when orally administered with the same dose of Imiquimod. These results indicate that compound 4 is superior to Imiquimod with respect to efficacy and safety.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901909     DOI: 10.1016/s0968-0896(03)00369-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Structural assignment of 6-oxy purine derivatives through computational modeling, synthesis, X-ray diffraction, and spectroscopic analysis.

Authors:  Xinyun Zhao; Xi Chen; Guang-Fu Yang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-05-27       Impact factor: 2.991

2.  Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues.

Authors:  Nikunj M Shukla; Subbalakshmi S Malladi; Cole A Mutz; Rajalakshmi Balakrishna; Sunil A David
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

3.  Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity.

Authors:  M Biffen; H Matsui; S Edwards; A J Leishman; K Eiho; E Holness; G Satterthwaite; I Doyle; H Wada; N J Fraser; S L Hawkins; M Aoki; H Tomizawa; A D Benjamin; H Takaku; T McInally; C M Murray
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives.

Authors:  Hélène G Bazin; Yufeng Li; Juhienah K Khalaf; Sandra Mwakwari; Mark T Livesay; Jay T Evans; David A Johnson
Journal:  Bioorg Med Chem Lett       Date:  2015-01-31       Impact factor: 2.823

Review 5.  The therapeutic potential of Toll-like receptor 7 stimulation in asthma.

Authors:  Matthew G Drake; Elad H Kaufman; Allison D Fryer; David B Jacoby
Journal:  Inflamm Allergy Drug Targets       Date:  2012-12

6.  Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines.

Authors:  Deepak B Salunke; Euna Yoo; Nikunj M Shukla; Rajalakshmi Balakrishna; Subbalakshmi S Malladi; Katelyn J Serafin; Victor W Day; Xinkun Wang; Sunil A David
Journal:  J Med Chem       Date:  2012-09-07       Impact factor: 7.446

7.  Synthetic and biological studies of tubulin targeting c2-substituted 7-deazahypoxanthines derived from marine alkaloid rigidins.

Authors:  Robert Scott; Menuka Karki; Mary R Reisenauer; Roberta Rodrigues; Ramesh Dasari; W Ross Smith; Stephen C Pelly; Willem A L van Otterlo; Charles B Shuster; Snezna Rogelj; Igor V Magedov; Liliya V Frolova; Alexander Kornienko
Journal:  ChemMedChem       Date:  2014-03-18       Impact factor: 3.466

8.  Synthetic Toll-like Receptors 7 and 8 Agonists: Structure-Activity Relationship in the Oxoadenine Series.

Authors:  Jay T Evans; Laura S Bess; Sandra C Mwakwari; Mark T Livesay; Yufeng Li; Van Cybulski; David A Johnson; Hélène G Bazin
Journal:  ACS Omega       Date:  2019-09-10

Review 9.  TLRs in pulmonary diseases.

Authors:  Shweta Arora; Shaniya Ahmad; Rasha Irshad; Yamini Goyal; Sahar Rafat; Neha Siddiqui; Kapil Dev; Mohammad Husain; Shakir Ali; Anant Mohan; Mansoor Ali Syed
Journal:  Life Sci       Date:  2019-07-20       Impact factor: 5.037

Review 10.  Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles.

Authors:  Deepender Kaushik; Arshpreet Kaur; Nikolai Petrovsky; Deepak B Salunke
Journal:  RSC Med Chem       Date:  2021-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.